$SOTK
SONO TEK CORP Stock $sotk

$sotk Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000117152023000181 Filed on May 25, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$3.603M	$3.657M	$15.06M
YoY Change	-11.07%	-26.83%	-12.11%
Cost Of Revenue	$1.826M	$1.832M	$7.406M
YoY Change	-6.11%	-24.99%	-13.07%
Gross Profit	$1.777M	$1.825M	$7.652M
YoY Change	-15.65%	-28.6%	-11.15%
Gross Profit Margin	49.33%	49.9%	50.82%
Selling, General & Admin	$1.212M	$1.197M	$4.819M
YoY Change	0.21%	-18.13%	-3.49%
% of Gross Profit	68.22%	65.61%	62.98%
Research & Development	$656.4K	$606.2K	$2.150M
YoY Change	27.06%	24.74%	24.29%
% of Gross Profit	36.94%	33.22%	28.09%
Depreciation & Amortization	$135.2K	$144.6K	$510.9K
YoY Change	25.61%	42.07%	17.3%
% of Gross Profit	7.61%	7.92%	6.68%
Operating Expenses	$1.869M	$1.804M	$6.969M
YoY Change	8.25%	-7.44%	3.66%
Operating Profit	-$91.61K	$21.40K	$683.0K
YoY Change	-124.07%	-96.48%	-63.85%
Interest Expense	$123.7K	$82.45K	$106.9K
YoY Change	-2884.91%	-2230.49%	1025.47%
% of Operating Profit		385.28%	15.65%
Other Income/Expense, Net
YoY Change
Pretax Income	$32.03K	$103.9K	$789.9K
YoY Change	-91.48%	-82.79%	-72.8%
Income Tax	-$21.37K	$40.61K	$154.0K
% Of Pretax Income	-66.72%	39.1%	19.5%
Net Earnings	$53.41K	$63.25K	$635.9K
YoY Change	-82.52%	-88.62%	-74.99%
Net Earnings / Revenue	1.48%	1.73%	4.22%
Basic Earnings Per Share	$0.00		$0.04
Diluted Earnings Per Share	$0.00	$0.00	$0.04
COMMON SHARES
Basic Shares Outstanding	15.74M shares	15.74M shares	15.74M shares
Diluted Shares Outstanding	15.77M shares		15.77M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.14M	$11.44M	$11.44M
YoY Change	9.64%	6.87%	6.87%
Cash & Equivalents	$4.294M	$3.355M	$3.355M
Short-Term Investments	$7.847M	$8.090M	$8.090M
Other Short-Term Assets	$189.3K	$254.1K	$254.1K
YoY Change	-8.5%	-21.42%	-21.42%
Inventory	$3.755M	$3.243M	$3.243M
Prepaid Expenses
Receivables	$1.141M	$1.634M	$1.634M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$17.23M	$16.58M	$16.58M
YoY Change	10.0%	14.33%	14.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.893M	$2.625M	$2.875M
YoY Change	4.71%	-6.62%	2.27%
Goodwill
YoY Change
Intangibles	$53.19K	$57.20K
YoY Change	-25.34%	-24.75%
Long-Term Investments
YoY Change
Other Assets	$726.8K	$667.1K	$667.1K
YoY Change	184.55%	177.1%	177.1%
Total Long-Term Assets	$3.673M	$3.599M	$3.599M
YoY Change	18.89%	15.07%	15.07%
TOTAL ASSETS
Total Short-Term Assets	$17.23M	$16.58M	$16.58M
Total Long-Term Assets	$3.673M	$3.599M	$3.599M
Total Assets	$20.90M	$20.17M	$20.17M
YoY Change	11.47%	14.46%	14.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$933.6K	$810.9K	$810.9K
YoY Change	-5.03%	18.46%	18.46%
Accrued Expenses	$1.339M	$1.427M	$1.427M
YoY Change	-20.68%	-20.87%	-20.87%
Deferred Revenue	$3.611M	$2.838M
YoY Change		143.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.146M	$5.458M	$5.458M
YoY Change	37.61%	46.9%	46.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.146M	$5.458M	$5.458M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.164M	$5.541M	$5.541M
YoY Change	33.04%	42.65%	42.65%
SHAREHOLDERS EQUITY
Retained Earnings	$4.963M	$4.910M
YoY Change	8.38%	14.88%
Common Stock	$157.4K	$157.4K
YoY Change	0.08%	0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.74M	$14.63M	$14.63M
YoY Change
Total Liabilities & Shareholders Equity	$20.90M	$20.17M	$20.17M
YoY Change	11.47%	14.46%	14.46%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	$53.41K	$63.25K	$635.9K
YoY Change	-82.52%	-88.62%	-74.99%
Depreciation, Depletion And Amortization	$135.2K	$144.6K	$510.9K
YoY Change	25.61%	42.07%	17.3%
Cash From Operating Activities	$828.1K	$330.5K	$1.325M
YoY Change	91.83%	-34.81%	-42.87%
INVESTING ACTIVITIES
Capital Expenditures	$149.0K	$142.3K	$555.9K
YoY Change	174.24%	-437.8%	-270.02%
Acquisitions
YoY Change
Other Investing Activities	$260.7K	-$9.570K	-$2.255M
YoY Change	-89.39%	-99.62%	72.87%
Cash From Investing Activities	$111.7K	-$151.9K	-$2.811M
YoY Change	-95.35%	-94.07%	72.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	828.1K	330.5K	$1.325M
Cash From Investing Activities	111.7K	-151.9K	-$2.811M
Cash From Financing Activities		0.000
Net Change In Cash	939.7K	178.6K	-$1.486M
YoY Change	-66.85%	-108.96%	-296.43%
FREE CASH FLOW
Cash From Operating Activities	$828.1K	$330.5K	$1.325M
Capital Expenditures	$149.0K	$142.3K	$555.9K
Free Cash Flow	$679.1K	$188.1K	$769.2K
YoY Change	79.96%	-65.74%	-70.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022Q1	sotk	Capitalized Rd Expenses Irc Section174 CapitalizedRdExpensesIrcSection174		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000806172
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2023	sotk	Gain From Forgiveness Of Paycheck Protection Program Loan GainFromForgivenessOfPaycheckProtectionProgramLoan		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	sotk	Accounts Receivable Reserve AccountsReceivableReserve		usd
CY2023	sotk	Paycheck Protection Program Loan Forgiveness PaycheckProtectionProgramLoanForgiveness		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-02-28
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2023	dei	Entity File Number EntityFileNumber	000-16035
CY2023	dei	Entity Registrant Name EntityRegistrantName	Sono Tek Corp
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	14-1568099
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2012 Route 9W
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Milton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	12547
CY2023	dei	City Area Code CityAreaCode	(845)
CY2023	dei	Local Phone Number LocalPhoneNumber	795-2020
CY2023	dei	Security12b Title Security12bTitle	Common Stock $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	SOTK
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	81462747	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15742073	shares
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Friedman LLP
CY2022	dei	Auditor Firm AuditorFirmId	711
CY2023	dei	Auditor Location AuditorLocation	East Hanover, New Jersey
CY2022	dei	Auditor Location AuditorLocation	East Hanover, New Jersey
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3354601	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4840558	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8090000	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5867990	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12225	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	56123	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1633866	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1092505	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3242909	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	2373242	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	254046	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	323304	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	16575422	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	14497599	usd
CY2023Q1	us-gaap	Land Land	250000	usd
CY2022Q1	us-gaap	Land Land	250000	usd
CY2023Q1	sotk	Buildings Equipment Furnishings And Leasehold Improvements Net BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet	2624996	usd
CY2022Q1	sotk	Buildings Equipment Furnishings And Leasehold Improvements Net BuildingsEquipmentFurnishingsAndLeaseholdImprovementsNet	2561184	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	57202	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	76015	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	667098	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	240736	usd
CY2023Q1	us-gaap	Assets Assets	20174718	usd
CY2022Q1	us-gaap	Assets Assets	17625534	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	810863	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	684511	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1427446	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1804028	usd
CY2023Q1	sotk	Customer Deposits CustomerDeposits	2838165	usd
CY2022Q1	sotk	Customer Deposits CustomerDeposits	1167968	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	381421	usd
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	58874	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5457895	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3715381	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	82865	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	168840	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5540760	usd
CY2022Q1	us-gaap	Liabilities Liabilities	3884221	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15742073	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15742073	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15729175	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15729175	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	157421	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	157292	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9566898	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9310287	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4909639	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4273734	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14633958	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13741313	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20174718	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17625534	usd
CY2023	us-gaap	Revenues Revenues	15058203	usd
CY2022	us-gaap	Revenues Revenues	17132710	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	7406196	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	8520156	usd
CY2023	us-gaap	Gross Profit GrossProfit	7652007	usd
CY2022	us-gaap	Gross Profit GrossProfit	8612554	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2149525	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1729509	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3169730	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3367403	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1649761	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1626306	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6969016	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6723218	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	682991	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1889336	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	140042	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	9496	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-33119	usd
CY2022	sotk	Gain From Forgiveness Of Paycheck Protection Program Loan GainFromForgivenessOfPaycheckProtectionProgramLoan	1005372	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	789914	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2904204	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154009	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	361631	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2022	us-gaap	Profit Loss ProfitLoss	2542573	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15735451	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15586404	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15769499	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15623485	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	10950682	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	179283	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	68775	usd
CY2022	us-gaap	Profit Loss ProfitLoss	2542573	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13741313	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	256740	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14633958	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2022	us-gaap	Profit Loss ProfitLoss	2542573	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	510868	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	435525	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	256740	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	179283	usd
CY2023	sotk	Accounts Receivable Reserve AccountsReceivableReserve	43898	usd
CY2023	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	4864	usd
CY2022	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	43381	usd
CY2022	sotk	Paycheck Protection Program Loan Forgiveness PaycheckProtectionProgramLoanForgiveness	1005372	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-33119	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-512337	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17620	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	497463	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-665297	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	874531	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-194483	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-69258	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	171988	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	126352	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-606241	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-376582	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	53112	usd
CY2023	sotk	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	1670197	usd
CY2022	sotk	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	1427	usd
CY2023	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	322547	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	5307	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1325039	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2319167	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	555867	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	326942	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	2255129	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1304520	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2810996	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1631462	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	68775	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68775	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1485957	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	756480	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4840558	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4084078	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3354601	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4840558	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	363590	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	373928	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	297500	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	178500	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2892000	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8090000	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5867990	usd
CY2023Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	8090000	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5867990	usd
CY2023Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q1	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P17Y
CY2022Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	202681	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	192490	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	11000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	11000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	11000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P40Y
CY2023Q1	us-gaap	Land Land	250000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zOpTtxHycy01" style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i><span id="xdx_861_zoN7be49pejc">Management Estimates</span></i></b><i> - </i>The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"><b><i> </i></b></p>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhZzJAtMVTv" style="font: 11pt Cambria,serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in"><b><i><span id="xdx_867_zGz3lzCZGSB5">Reclassifications</span> - </i></b>Building, equipment, leasehold improvements reclassifications have been made to the fiscal 2022 consolidated financial statements to conform to the fiscal 2023 consolidated financial statement presentation. These reclassifications had no effect on net loss or cash flows as previously reported.</p> <p style="font: 11pt Cambria,serif; margin: 0; text-align: justify"> </p>
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2149000	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1730000	usd
CY2023Q1	sotk	Cash Deposits CashDeposits	2838000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	145000	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	145000	usd
CY2022Q1	sotk	Cash Deposits CashDeposits	1168000	usd
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	5000	usd
CY2022	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	5000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	431190	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1427446	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1804028	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	38536	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	508459	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	333500	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.35
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.17
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M26D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	168335	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.10
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	403334	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.12
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	19750	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.27
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253710	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	61690	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.46
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.53
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y11M8D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	44739	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.71
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16973	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.77
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	30717	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.66
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	250759	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	133609	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.62
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	155077	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	256740	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	179283	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	288000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12898	shares
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	438263	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0282	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0402	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0078	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.020	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.5502	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.6201	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.5073	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.5713	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1868689	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	1250589	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	613915	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	779533	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	760305	usd
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	343120	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	3242909	usd
CY2022Q1	us-gaap	Inventory Gross InventoryGross	2373242	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	341882	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	83525	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8934703	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8461695	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6309707	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5900511	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2624996	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2561184	usd
CY2023	us-gaap	Depreciation Depreciation	492055	usd
CY2022	us-gaap	Depreciation Depreciation	416083	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	352619	usd
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	449673	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	500650	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	622775	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	157927	usd
CY2022Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	195540	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	100921	usd
CY2022Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	104850	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	315329	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	165882	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	609883	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	37204	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	37894	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	127329	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	101573	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	78252	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-179320	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-5253	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154009	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	361631	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	521788	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	380418	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-321458	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-18787	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-46321	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-367779	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-18787	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154009	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	361631	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	76000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	69000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	12000	usd
CY2023Q1	sotk	Capitalized Rd Expenses Irc Section174 CapitalizedRdExpensesIrcSection174	441000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	147000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	160000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	667000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	241000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	83000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	169000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	83000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	169000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	635905	usd
CY2022	us-gaap	Profit Loss ProfitLoss	2542573	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15735451	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15586404	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	34048	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	37081	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15769499	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15623485	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8254000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11653000	usd

Files In Submission

Name	View Source	Status
0001171520-23-000181-index-headers.html	Edgar Link	pending
0001171520-23-000181-index.html	Edgar Link	pending
0001171520-23-000181.txt	Edgar Link	pending
0001171520-23-000181-xbrl.zip	Edgar Link	pending
eps10796_sotk.htm	Edgar Link	pending
ex21.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
eps10796_sotk_htm.xml	Edgar Link	completed
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sotk-20230228.xsd	Edgar Link	pending
sotk-logo.jpg	Edgar Link	pending
sotk-20230228_cal.xml	Edgar Link	unprocessable
sotk-20230228_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
sotk-20230228_pre.xml	Edgar Link	unprocessable
sotk-20230228_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SOTK
SONO TEK CORP Stock $sotk

2023 Q2 Form 10-K Financial Statement

#000117152023000181 Filed on May 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOTK SONO TEK CORP Stock $sotk

2023 Q2 Form 10-K Financial Statement

#000117152023000181 Filed on May 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SOTK
SONO TEK CORP Stock $sotk